Mobile health app for monitoring allergic rhinitis and asthma in real life in Lithuanian MASK‐air users
Open Access
- 25 September 2022
- journal article
- research article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 12 (9) , e12192
Abstract
Background: MASK‐air® is an app whose aim is to reduce the global burden of allergic rhinitis (AR) and asthma. A transfer of innovative practices was performed to disseminate and implement MASK‐air® in European regions. The aim of the study was to examine the implementation of the MASK‐air® app in Lithuanian adults in order to investigate (i) the rate of acceptance in this population, (ii) the duration of app use and (iii) the evaluation of the app after its use.Methods: In a longitudinal study, Lithuanian adults with AR and/or asthma were recruited by allergists. They were informed about how to use MASK‐air® and were followed closely. They were reviewed after one to 3 months to evaluate satisfaction and were asked to continue using the app.Results: Among the 149 patients recruited (37.2 ± 10.4 years), 52.4% had rhinitis alone, 42.9% had rhinitis, asthma and/or conjunctivitis multimorbidity, and 2.7% isolated asthma. According to the MASK‐air® baseline questionnaire, 88.3% of patients considered that their symptoms were troublesome. Data were available for 102 (68.4%) patients. The duration of app usage in patients ranged from 1 to 680 days (median, 25–75 percentile: 54, 23.2–151 days). Forty‐two (41.1% of patients who were reviewed) patients agreed to share their opinion on MASK‐air®. Most users of the app were satisfied, from 46.5% thinking their allergy was treated more successfully to 90.4% recommending this app to other allergy sufferers.Discussion: When recommended by physicians, MASK‐air® was used for a longer period of time.Keywords
This publication has 23 references indexed in Scilit:
- Geolocation with respect to personal privacy for the Allergy Diary app - a MASK studyWorld Allergy Organization Journal, 2018
- Digital health is a cultural transformation of traditional healthcaremHealth, 2017
- Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)Allergy, 2017
- Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis studyAllergy, 2017
- ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycleClinical and Translational Allergy, 2016
- MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementationAllergy, 2015
- MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis.2015
- Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthmaAllergy, 2010
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- Letters to the EditorInternational Journal of Epidemiology, 1995